Hemoglobin A1c levels and mortality in the diabetic hemodialysis population: Findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS)

Diabetes Care

Volumn 35, Issue 12, 2012, Pages 2527-2532

  Ramirez, Sylvia Paz B ^a   McCullough, Keith P ^a   Thumma, Jyothi R ^a   Nelson, Robert G ^b   Morgenstern, Hal ^a,c   Gillespie, Brenda W ^c   Inaba, Masaaki ^d   Jacobson, Stefan H ^e   Vanholder, Raymond ^f   Pisoni, Ronald L ^a   Port, Fritz K ^a,c   Robinson, Bruce M ^a,c  

^a ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d Osaka Prefecture University   (Japan)

^e DANDERYD HOSPITAL   (Sweden)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; SERUM ALBUMIN;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; AUSTRALIA; BELGIUM; BODY MASS; CANADA; COHORT ANALYSIS; COMORBIDITY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; FRANCE; GENDER; GERMANY; GLYCEMIC CONTROL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; ITALY; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; PREDICTIVE VALUE; PROSPECTIVE STUDY; RACE; RANDOM SAMPLE; SPAIN; SWEDEN; UNITED KINGDOM; UNITED STATES;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 84869857901     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0573     Document Type: Article

References (25)

1. Foley RN, Collins AJ. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol 2007;18:2644-2648 (Pubitemid 47531190)
2. Little RR, Tennill AL, Rohlfing C, et al. Can glycohemoglobin be used to assess glycemic control in patients with chronic renal failure? Clin Chem 2002;48:784-786 (Pubitemid 34439117)
3. Nakao T, Matsumoto H, Okada T, et al. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Intern Med 1998;37:826-830
4. 1C and survival in maintenance hemodialysis patients.Diabetes Care 2007;30: 1049-1055
5. Williams ME. Diabetic CKD/ESRD 2010: a progress report? Semin Dial 2010;23: 129-133
6. Williams ME, Lacson E Jr, Teng M, Ofsthun N, Lazarus JM. Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. Kidney Int 2006;70:1503-1509 (Pubitemid 44527322)
7. American Diabetes Association (ADA). Clinical Practice Recommendations, 2012 Available at: http://professional.diabetes.org/CPR-search.aspx. 2012
8. KDOQI. KDOQI Clinical Practice Guidelines Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007;49(2 Suppl. 2): S12-S154
9. Hayashino Y, Fukuhara S, Akiba T, et al. Diabetes, glycaemic control and mortality risk in patients on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study.Diabetologia 2007;50:1170-1177 (Pubitemid 46701557)
10. Raghunathan TE, Solenberger PW, Van Hoewyk J. IVEware: Imputation and variance estimation software. Ann Arbor, MI, Survey Methodology Program, Survey Research Center, Institute for Social Research, University of Michigan. 2002
11. SAS/STAT Software. Version 9.2 of the SAS System for Windows [computer program]. Cary, NC, SAS, 2011
12. Freedman BI, Andries L, Shihabi ZK, et al. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. Clin J Am Soc Nephrol 2011;6:1635-1643
13. Shurraw S, Majumdar SR, Thadhani R, Wiebe N, Tonelli M; Alberta Kidney Disease Network. Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis. Am J Kidney Dis 2010;55:875-884
14. Molnar MZ, Ricks JL, Kovesdy CP, et al. Glycemic control and mortality in hemodialysis patients with diabetes mellitus: a six-year cohort study [AbstractTH-OR085]. J Am Soc Nephrol 2011;22:21A
15. Oomichi T, Emoto M, Tabata T, et al. Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study. Diabetes Care 2006;29:1496-1500 (Pubitemid 44127570)
16. Action to Control Cardiovascular Risk in Diabetes Study Group; Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes.NEngl JMed 2008; 358:2545-2559
17. Inaba M, Okuno S, Kumeda Y, et al.; Osaka CKD Expert Research Group. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 2007;18:896-903 (Pubitemid 46434506)
18. Mehrotra R, Duong U, Jiwakanon S, et al. Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. Am J Kidney Dis 2011;58:418-428
19. Vos FE, Schollum JB, Walker RJ. Glycated albumin is the preferred marker for assessing glycemic control in advanced chronic kidney disease. NDT Plus 2011;4:368-375
20. Michelis R, Kristal B, Snitkovsky T, Sela S. Oxidative modifications impair albumin quantification. Biochem Biophys Res Commun 2010;401:137-142
21. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan DM, Peterson CM; American Diabetes Association. Tests of glycemia in diabetes. Diabetes Care 2004; 27(Suppl. 1):S91-S93
22. Shrishrimal K, Hart P, Michota F. Managing diabetes in hemodialysis patients: observations and recommendations. Cleve Clin J Med 2009;76:649-655
23. Lim VS, Kopple JD. Protein metabolism in patients with chronic renal failure: role of uremia and dialysis. Kidney Int 2000;58: 1-10 (Pubitemid 30429844)
24. Combe C, McCullough KP, Asano Y, Ginsberg N, Maroni BJ, Pifer TB. Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): nutrition guidelines, indicators, and practices. Am J Kidney Dis 2004;44(Suppl. 2): 39-46
25. Kovesdy CP, Park JC, Kalantar-Zadeh K. Glycemic control and burnt-out diabetes in ESRD. Semin Dial 2010;23:148-156